je.st
news
Tag: meeting
Meeting agenda - May 18, 2016
2016-05-19 00:32:17| PortlandOnline
PDF Document, 106kbCategory: Agendas
Tags: meeting
agenda
meeting agenda
agenda meeting
January 26, 2016 Board Meeting Minutes
2016-05-19 00:27:02| PortlandOnline
PDF Document, 1,793kbCategory: Minutes
Tags: january
board
minutes
meeting
November 17, 2015 Board Meeting Minutes
2016-05-19 00:26:10| PortlandOnline
PDF Document, 2,106kbCategory: Minutes
Tags: november
board
minutes
meeting
New KEYTRUDA (pembrolizumab) Data from KEYNOTE-006 and KEYNOTE-001 in Advanced Melanoma, Including Updated Survival Data, To Be Presented at 2016 ASCO Annual Meeting
2016-05-18 23:19:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Final Overall Survival Data from KEYNOTE-006 To Be Presented at ASCO; KEYTRUDA, the First Anti-PD-1 Monotherapy to Demonstrate Overall Survival Compared to Ipilimumab, Shows Continued Benefit with Longer Follow-Up KEYNOTE-001 Findings Show Continued Benefit in Response Rates, Duration of Response, and Include New Three-Year Overall Survival Data for KEYTRUDA KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced final overall survival (OS) data from KEYNOTE-006 and new findings from KEYNOTE-001, including updated response rates, duration of response data and three-year OS data with KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in patients with unresectable or metastatic melanoma. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558An Phan, 908-255-6325orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: including
data
advanced
updated
Inclusionary Housing Panel Meeting Schedule
2016-05-18 19:45:04| PortlandOnline
IZ Panel Meeting Schedule PDF Document, 86kbCategory: Inclusionary Housing
Tags: meeting
panel
schedule
housing
Sites : [421] [422] [423] [424] [425] [426] [427] [428] [429] [430] [431] [432] [433] [434] [435] [436] [437] [438] [439] [440] next »